Lipid-based antifungal agents.
Arikan
Sevtap
S
Hacettepe University Medical School, Department of Microbiology and Clinical Microbiology, Mycology Laboratory, 06100 Ankara, Turkey. sarikan@metu.edu.tr
D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D008055:Lipids / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy*; D009761:Nystatin / Q000627:therapeutic use*; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D010715:Phosphatidylglycerols / Q000627:therapeutic use*
D000935:Antifungal Agents; D004338:Drug Combinations; D008055:Lipids; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D009761:Nystatin; D000666:Amphotericin B